


Healthcare News Roundup: Interventional Cardiology
HSMN NewsFeed - 19 Mar 2009
Cook Incorporated Resolves To Pursue Further German Infringement Action Against Edwards Lifesciences
Cook Incorporated Resolves To Pursue Further German Infringement Action Against Edwards Lifesciences
HSMN NewsFeed - 19 Mar 2009
Edwards Lifesciences Prevails in German Patent Infringement Case Initiated by Cook
Edwards Lifesciences Prevails in German Patent Infringement Case Initiated by Cook
HSMN NewsFeed - 19 Mar 2009
XTENT Receives CE Mark Approval for CUSTOM NX (R) Drug-Eluting Stent System
XTENT Receives CE Mark Approval for CUSTOM NX (R) Drug-Eluting Stent System
HSMN NewsFeed - 12 Mar 2009
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent
HSMN NewsFeed - 11 Mar 2009
Journal of the American College of Cardiology Publishes PROTECT I Study Results for Abiomed Impella 2.5
Journal of the American College of Cardiology Publishes PROTECT I Study Results for Abiomed Impella 2.5
HSMN NewsFeed - 3 Mar 2009
Boston Scientific Announces Japanese Launch of Taxus(R) Liberte(R) Drug-Eluting Stent System
Boston Scientific Announces Japanese Launch of Taxus(R) Liberte(R) Drug-Eluting Stent System
HSMN NewsFeed - 18 Feb 2009
New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial
New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial
HSMN NewsFeed - 17 Feb 2009
CorNova(R) Expands Management Team with Appointment of Robert Gallahue as Chief Financial Officer
CorNova(R) Expands Management Team with Appointment of Robert Gallahue as Chief Financial Officer
HSMN NewsFeed - 10 Feb 2009
NMT Medical Appoints Board Member Frank Martin Interim President & Chief Executive Officer
NMT Medical Appoints Board Member Frank Martin Interim President & Chief Executive Officer
HSMN NewsFeed - 5 Feb 2009
Hospitals, Healthcare Providers to Save with New Premier Drug Eluting Coronary Stents Agreements
Hospitals, Healthcare Providers to Save with New Premier Drug Eluting Coronary Stents Agreements
HSMN NewsFeed - 4 Feb 2009
Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
HSMN NewsFeed - 2 Feb 2009
Cardiac Dimensions(R) Inc. Receives CE Mark for CARILLON Mitral Contour System
Cardiac Dimensions(R) Inc. Receives CE Mark for CARILLON Mitral Contour System
